Cargando…

Body-weight variability and risk of cardiovascular outcomes in patients with type 1 diabetes: a retrospective observational analysis of data from the DCCT/EDIC population

BACKGROUND: Cardiovascular risk and body-weight management are both emerging challenges of type 1 diabetes care. We evaluated the association between intraindividual variability of body-weight and risk of cardiovascular events in people with type 1 diabetes. METHODS: We analyzed 1,398 participants f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petria, Iulia, Albuquerque, Samuel, Varoquaux, Gaël, Vie, Jill-Jênn, Venteclef, Nicolas, Mohammedi, Kamel, Roussel, Ronan, Camoin, Marion, Perseghin, Gianluca, Velho, Gilberto, Potier, Louis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670666/ https://www.ncbi.nlm.nih.gov/pubmed/36397092 http://dx.doi.org/10.1186/s12933-022-01689-0

Ejemplares similares

SGLT2 inhibitors and lower limb complications: the diuretic-induced hypovolemia hypothesis
por: Potier, Louis, et al.
Publicado: (2021)

Serum urate and cardiovascular events in the DCCT/EDIC study
por: Jenkins, Alicia J., et al.
Publicado: (2021)

Recording of Diabetes on Death Certificates of Decedents With Type 1 Diabetes in DCCT/EDIC
por: McEwen, Laura N., et al.
Publicado: (2018)

The Association of Skin Intrinsic Fluorescence With Type 1 Diabetes Complications in the DCCT/EDIC Study
por: Orchard, Trevor J., et al.
Publicado: (2013)

Mediation of the Effect of Glycemia on the Risk of CVD Outcomes in Type 1 Diabetes: The DCCT/EDIC Study
por: Bebu, Ionut, et al.
Publicado: (2019)

Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study
por: Bebu, Ionut, et al.
Publicado: (2020)

Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2016)

Leukocyte telomere length, allelic variations in related genes and risk of coronary heart disease in people with long-standing type 1 diabetes
por: Sanchez, Manuel, et al.
Publicado: (2022)

Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications
por: Lopes-Virella, Maria F., et al.
Publicado: (2008)

Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study
por: Tang, W.H. Wilson, et al.
Publicado: (2018)

Risk Factors for Longitudinal Resting Heart Rate and Its Associations With Cardiovascular Outcomes in the DCCT/EDIC Study
por: Keshavarzi, Sareh, et al.
Publicado: (2021)

Effects of Prior Intensive Versus Conventional Therapy and History of Glycemia on Cardiac Function in Type 1 Diabetes in the DCCT/EDIC
por: Genuth, Saul M., et al.
Publicado: (2013)

Sexual Dysfunction in Women With Type 1 Diabetes: Long-term findings from the DCCT/ EDIC study cohort
por: Enzlin, Paul, et al.
Publicado: (2009)

Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study
por: Gubitosi-Klug, Rose A., et al.
Publicado: (2017)

Coronary Artery Disease Events and Carotid Intima‐Media Thickness in Type 1 Diabetes in the DCCT/EDIC Cohort
por: Polak, Joseph F., et al.
Publicado: (2021)

Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC
por: Monnier, Vincent M, et al.
Publicado: (2022)

OR14-4 Early Glomerular Hyperfiltration and Long Term Kidney Outcomes in Type 1 Diabetes: The DCCT/EDIC Experience
por: Molitch, Mark, et al.
Publicado: (2019)

Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2022)

Lower extremity arterial disease in patients with diabetes: a contemporary narrative review
por: Nativel, Mathilde, et al.
Publicado: (2018)

Effect of Prior Intensive Therapy in Type 1 Diabetes on 10-Year Progression of Retinopathy in the DCCT/EDIC: Comparison of Adults and Adolescents
por: White, Neil H., et al.
Publicado: (2010)

Self-Reported Autoimmune Disease by Sex in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study
por: Buschur, Elizabeth, et al.
Publicado: (2014)

Significance of Epicardial and Intrathoracic Adipose Tissue Volume among Type 1 Diabetes Patients in the DCCT/EDIC: A Pilot Study
por: Darabian, Sirous, et al.
Publicado: (2016)

Differential prognostic burden of cardiovascular disease and lower-limb amputation on the risk of all-cause death in people with long-standing type 1 diabetes
por: Camoin, Marion, et al.
Publicado: (2022)

Vibration Perception Threshold as a Measure of Distal Symmetrical Peripheral Neuropathy in Type 1 Diabetes: Results from the DCCT/EDIC study
por: Martin, Catherine L., et al.
Publicado: (2010)

Relationship of Glycated Albumin to Blood Glucose and HbA(1c) Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study
por: Nathan, David M., et al.
Publicado: (2014)

Effect of Intensive Diabetes Therapy on the Progression of Diabetic Retinopathy in Patients With Type 1 Diabetes: 18 Years of Follow-up in the DCCT/EDIC
Publicado: (2015)

Longitudinal Association Between Endothelial Dysfunction, Inflammation, and Clotting Biomarkers With Subclinical Atherosclerosis in Type 1 Diabetes: An Evaluation of the DCCT/EDIC Cohort
por: Hunt, Kelly J., et al.
Publicado: (2015)

Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes
por: Velho, Gilberto, et al.
Publicado: (2018)

Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study
por: Braffett, Barbara H., et al.
Publicado: (2019)

Progression of Carotid Artery Intima-Media Thickness During 12 Years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study
por: Polak, Joseph F., et al.
Publicado: (2011)

Plasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria
por: Velho, Gilberto, et al.
Publicado: (2013)

Effect of Glycemic Treatment and Microvascular Complications on Menopause in Women With Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort
por: Kim, Catherine, et al.
Publicado: (2014)

Data on carotid intima-media thickness and lipoprotein subclasses in type 1 diabetes from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC)
por: Basu, Arpita, et al.
Publicado: (2015)

Erratum. Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2017;40:1010–1016
por: Gubitosi-Klug, Rose A., et al.
Publicado: (2021)

Manganese Superoxide Dismutase (SOD2) Polymorphisms, Plasma Advanced Oxidation Protein Products (AOPP) Concentration and Risk of Kidney Complications in Subjects with Type 1 Diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2014)

Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC)
por: Lachin, John M., et al.
Publicado: (2021)

Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study
por: Albers, James W., et al.
Publicado: (2010)

Quality Control Measures over 30 Years in a Multicenter Clinical Study: Results from the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study
por: Lorenzi, Gayle M., et al.
Publicado: (2015)

Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID‐19 in type 2 diabetes
por: Alzaid, Fawaz, et al.
Publicado: (2020)

Effect of Intensive Glycemic Control and Diabetes Complications on Lower Urinary Tract Symptoms in Men With Type 1 Diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study
por: Van Den Eeden, Stephen K., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_8rubo6ei40i6v80n4luf9nrc3c